// App-Quantinova.ai

: Risk Factors for Thrombosis in Patients Aged > 60 Years with Essential Thrombocythemia without Previous Thrombotic Events

Researchers

Presenter

  • Roberto Latagliata

Principal Investigators

  • Massimo Breccia

  • Ida Carmosino

  • Federico Vozella

  • Atelda Romano

  • Annalisa Biagi

  • Luca Maurillo

  • Malgorzata Monika Trawinska

  • Katia Paciaroni

  • Michelina Santopietro

  • Sabrina Leonetti Crescenzi

  • Ada D'Addosio

  • Caterina Tatarelli

  • Elisabetta Abruzzese

  • Ambra Di Veroli

  • Elena Rossi

  • Valerio De Stefano

  • Marco Montanaro

Medical Centers

  • Hematology, Belcolle Hospital, Viterbo, Italy

  • Latial Group for the Study of Myeloproliferative Neoplasms, Rome, Italy

  • Hematology, Villa San Pietro Hospital, Rome, Italy

  • Hematology, Istituto Nazionale Tumori Regina Elena - IFO, Rome, Italy

  • Hematology and Stem cell transplantation, Campus Biomedico University, Rome, Italy

  • Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy

  • Hematology, Sant'Andrea Hospital - University Sapienza of Rome, Roma, ITA

  • U.O. di Ematologia e Trapianti di cellule Staminali. A.O.S. S. Camillo-Forlanini, Rome, Italy

  • Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy

  • Department of Onco-Hematology, Policlinico Tor Vergata, Rome, Italy

  • Hematology S. Eugenio Hospital, ASL RM, Rome, Italy

  • S.C. Ematologia, Azienda Ospedaliera S Giovanni Addolorata, Roma, Italy

  • UOSD Hematology, ASL RM, Rome, Italy

  • Department of Hematology S. Eugenio Hospital, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A